Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma-Reference-Cited by-同舟云学术

Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma

Published:2024-01 Issue: Volume:148 Page:106635
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Capone Emily,Perrotti Vittoria,Cela Ilaria,Lattanzio Rossano,Togni Lucrezia,Rubini Corrado,Caponio Vito Carlo Alberto,Lo Muzio Lorenzo,Colasante Martina,Giansanti Francesco,Ippoliti Rodolfo,Iacobelli Stefano,Wick Michael J.,Spardy Burr Nicole,Sala Gianluca^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference21 articles.

1. Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials;Dillon;Head Neck,2016

2. Adenoid cystic carcinoma of the head and neck–a 20 years experience;Kokemueller;Int J Oral Maxillofac Surg,2004

3. Systemic therapies for salivary gland adenoid cystic carcinoma;Sahara;Am J Cancer Res,2021

4. Drug-based therapy for advanced adenoid cystic carcinoma: Current landscape and challenges based on an overview of registered clinical trials;Wagner;Crit Rev Oncol Hematol,2023

5. A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma;Miller;Cancers (Basel),2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions;Pharmacological Research;2024-09

2. Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages;Matrix Biology;2024-09

3. Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances;MedComm;2024-09

4. Serum LGALS3BP is a potential biomarker for interstitial lung disease in dermatomyositis;2024-04-18